Matches in Wikidata for { <http://www.wikidata.org/entity/Q63807757> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q63807757 description "clinical trial" @default.
- Q63807757 description "ensayu clínicu" @default.
- Q63807757 description "klinisch onderzoek" @default.
- Q63807757 description "клінічне випробування" @default.
- Q63807757 name "LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids" @default.
- Q63807757 type Item @default.
- Q63807757 label "LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids" @default.
- Q63807757 prefLabel "LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids" @default.
- Q63807757 P1050 Q63807757-4711E93A-7160-4017-9D6B-69CFE3F431A7 @default.
- Q63807757 P1050 Q63807757-916DCA60-F039-4CD0-8A66-0CBCB3595024 @default.
- Q63807757 P1132 Q63807757-67147317-0161-4F5D-BE87-AD8CFFC93373 @default.
- Q63807757 P1476 Q63807757-FAED45F8-5BF2-4BE3-AC63-5041098E499B @default.
- Q63807757 P17 Q63807757-0B8DCE24-EAFC-4E6B-9938-B9EB4F1FDEB5 @default.
- Q63807757 P17 Q63807757-2F51ED01-CD71-405B-A9F3-9B84BAE0573C @default.
- Q63807757 P17 Q63807757-84ED7A23-F950-45AD-BFFB-5B0C2EBA4E51 @default.
- Q63807757 P17 Q63807757-8D0E05D8-371F-4E4A-87DA-355A136BC882 @default.
- Q63807757 P17 Q63807757-96D627A0-9702-478F-A63F-D3D188DBA5C1 @default.
- Q63807757 P17 Q63807757-EB19F441-73BF-4477-8F02-62EE155C2F77 @default.
- Q63807757 P2899 Q63807757-D58A78E3-A648-4BCF-A5BA-4598C491D0B3 @default.
- Q63807757 P3098 Q63807757-5FFA0038-A7AD-42F4-B6C7-511370AE15F3 @default.
- Q63807757 P31 Q63807757-84C0B1C9-4950-4ADB-A606-B9D534E9800F @default.
- Q63807757 P4135 Q63807757-7154229F-9EA7-4105-AD61-8EE62F0DE12E @default.
- Q63807757 P580 Q63807757-1D1FDA0C-0C1F-4124-95F1-F62A7B35081C @default.
- Q63807757 P582 Q63807757-9BD17DDE-75DB-4677-998E-9B66EFF6ED3C @default.
- Q63807757 P6099 Q63807757-BF643B05-7970-49B0-8B4C-5B04C30F482B @default.
- Q63807757 P8363 Q63807757-5147B338-E735-41C1-B58F-1C3796F04BE6 @default.
- Q63807757 P1050 Q18556303 @default.
- Q63807757 P1050 Q4667534 @default.
- Q63807757 P1132 "+390" @default.
- Q63807757 P1476 "LIBERTY 2: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy & Safety Study of Relugolix Co-Administered With/Without Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids" @default.
- Q63807757 P17 Q155 @default.
- Q63807757 P17 Q258 @default.
- Q63807757 P17 Q28 @default.
- Q63807757 P17 Q298 @default.
- Q63807757 P17 Q31 @default.
- Q63807757 P17 Q36 @default.
- Q63807757 P2899 "+18" @default.
- Q63807757 P3098 "NCT03103087" @default.
- Q63807757 P31 Q30612 @default.
- Q63807757 P4135 "+50" @default.
- Q63807757 P580 "2017-03-28T00:00:00Z" @default.
- Q63807757 P582 "2019-09-30T00:00:00Z" @default.
- Q63807757 P6099 Q42824827 @default.
- Q63807757 P8363 Q78089383 @default.